Shire Newsroom: Media, News & Press Releases

shire map

Select a
Location

Shire Global

Europe

Americas

Asia Pacific

12/12/2018
Rule 2.9 announcement
12/11/2018
Rule 2.9 announcement
12/07/2018
Rule 2.9 announcement
12/06/2018
Rule 2.9 Announcement
12/05/2018
Results of Court Meeting and General Meeting
12/05/2018
Rule 2.9 announcement
12/04/2018
Holding(s) in Company
12/04/2018
Rule 2.9 announcement
12/03/2018
Rule 2.9 announcement
12/03/2018
Total Voting Rights
12/01/2018
Initial Data from Shire Collaboration Identifies Key Biomarkers That Affect Bleeding Patterns, Response to Treatment for Hemophilia A
11/30/2018
Shire Receives European Approval for TAKHZYRO™ (lanadelumab) subcutaneous injection, for the Preventive Treatment of Hereditary Angioedema
11/29/2018
Rule 2.9 announcement
11/27/2018
Shire plc: JAMA Publishes Complete Results of Phase 3 HELP Study™ Evaluating Lanadelumab as a Preventive Treatment for Hereditary Angioedema
11/27/2018
Rule 2.9 announcement
11/26/2018
Form 8 (DD) – Shire plc
11/23/2018
Block Listing Six Monthly Return
11/23/2018
Rule 2.9 announcement
11/22/2018
Rule 2.9 announcement
11/20/2018
Phase I conditional clearance by the European Commission
11/20/2018
Rule 2.9 announcement
11/16/2018
Rule 2.9 announcement
11/16/2018
Shire Announces New HELP Study(TM) Data for Lanadelumab in Hereditary Angioedema (HAE) at 2018 ACAAI Annual Scientific Meeting
11/14/2018
Rule 2.9 announcement
11/13/2018
U.S. FDA Accepts for Filing Shire’s Supplemental New Drug Application for GATTEX® (teduglutide [rDNA origin]) for Children with Short Bowel Syndrome

LOAD MORE

Media Contacts

External Communications

Katie Joyce
Communications & Public Affairs
KJoyce@shire.com

For All International Inquiries

Deborah Hibbett
Communications & Public Affairs
dhibbett@shire.com

Kirsty Langton
Communications & Public Affairs
kirsty.langton@shire.com

In This Section

medialibrary

Media Library

Learn more

socialmedia

Social Media

Learn more

Committed To Responsibility

We make decisions that put patients first.

Subscribe to Shire News Alerts

Sign up for and select the type of alerts you would like to receive by email.

TOP

Cookie Use Notification

The site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to our use of cookies as set out in our cookie notice. Please read our privacy notice for more information on the cookies we use and how to delete or block the use of cookies. LEARN MORE

CONTINUE DISAGREE